The use of human dura mater as an interposition graft in the treatment of vesicovaginal fistula

Basit Öğe Kaydı
dc.contributor.authorAlagol, Buelent
dc.contributor.authorGozen, Ali Serdar
dc.contributor.authorKaya, Esat
dc.contributor.authorInci, Osman
dc.date.accessioned2024-06-12T10:54:53Z
dc.date.available2024-06-12T10:54:53Z
dc.date.issued2003
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose: In this prospective study we aimed to describe our new technique; dehydrated human dura mater as an interposition graft in patients undergoing benign vesicovaginal fistula repair (VVF). Patients and methods: Eleven patients with benign VVFs aged 38-73 years were operated with dura mater interposition technique at our institution between July 1996 and February 2002. In all patients fistula were secondary to abdominal hysterectomies with benign diseases and two had undergone previous transvaginal surgery. Patients were operated 8-15 (mean 12) weeks after previous surgery. A suprapubic cystotomy was performed and the fistula was not excised. The bladder wall is widely dissected from underlying vagina. Dura-mater was placed over the vaginal suture line to close the fistulous tract, cytostomy was inserted and the bladder was closed. An 18 F Foley catheter was left in the bladder for 5 days. A successful repair is defined as no leakage by cystogram at 14 days postoperatively and completely dry by patient report. Results: An overall success rate of 100% was achieved in all patients. All patients remain dry at the follow - up which ranges from 7 to 60 (mean 26) mounts. Patients were discharged at 14 to 26 (mean 16) days postoperatively. No major complications or side effects were observed during the follow-up period. Conclusions: The use of human dura mater as an interposition graft in the treatment of vesicovaginal fistula is an alternative for VVF repairs because of its excellent tissue compability, stability, good elasticity and absorbability.en_US
dc.identifier.endpage40en_US
dc.identifier.issn0301-1623
dc.identifier.issn1573-2584
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-3042767227en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage35en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/19189
dc.identifier.volume36en_US
dc.identifier.wosWOS:000207621100009en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Urology And Nephrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBladderen_US
dc.subjectDura Materen_US
dc.subjectSurgeryen_US
dc.subjectVesicovaginal Fistulaen_US
dc.titleThe use of human dura mater as an interposition graft in the treatment of vesicovaginal fistulaen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu